Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Englmeier, C. Neurohr, P. Huppmann, W. von Wulffen, G. Zimmermann, S. Leuschner, T. Meis, J. Behr (Munich, Germany). Impact of pulmonary hypertension after lung transplantation on functional outcome. Eur Respir J 2010; 36: Suppl. 54, 3477

Member's Comments

No comment yet.

Related content which might interest you: Clinical characteristics and pulmonary function in patients with pulmonary fibrosis assessed for lung transplant Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010 Lung transplantation for pulmonary hypertension Source: Eur Respir Mon 2012; 57: 247-255 Year: 2012 Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease? Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Prognosis in patients with primary pulmonary hypertension awaiting lung transplantion Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001 Risk stratification in patients with pulmonary arterial hypertension (PAH) and candidates for lung or heart-lung transplantation Source: Virtual Congress 2021 – All about pulmonary arterial hypertension Year: 2021 Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung Source: Eur Respir J 2003; 21: 192-194 Year: 2003 Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation Source: Eur Respir J 2012; 39: 1520-1533 Year: 2012 Prevalence and echocardiographic screening for pulmonary hypertension in liver transplantation recipients Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Lung transplantation for pulmonary hypertension: the impact of new drug therapies Source: Annual Congress 2004 - Lung transplantation: new insights in advanced lung disease and new drug developments - do they impact on selection criteria? Year: 2004 Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Lung function tests and survival in idiopathic pulmonary fibrosis after lung transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005 Functional status following pulmonary rehabilitation in patients with interstitial lung disease Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease Year: 2021 ‘Idiopathic‘ pulmonary arterial hypertension with preserved lung function but co-existing parenchymal abnormalities: Response to treatment and survival Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries Year: 2012 Clinical characteristics, haemodynamics, and survival in patients with combined pulmonary fibrosis and emphysema and associated pulmonary hypertension Source: Annual Congress 2008 - Pulmonary vascular medicine Year: 2008 Effects of transplantation on lung and exercise physiology Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=220 Year: 2003 Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant Source: Eur Respir J 2007; 30: 715-721 Year: 2007 Impact of pulmonary metastasectomy on lung function parameters Source: Annual Congress 2012 - Special problems in thoracic surgery Year: 2012 Cardiac remodelling and hemodynamic changes in pulmonary hypertension after double lung transplantation Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Survival impact of lung transplantation for COPD Source: Eur Respir J 2010; 36: 74-80 Year: 2010 Relationship between pulmonary function and lung cancer surgery outcome Source: Eur Respir J 2004; 24: Suppl. 48, 478s Year: 2004